BioSpace News Archive

Companies combining their key strengths to provide enhanced integrated workflow software solution designed to provide superior infection prevention and practice optimization

A highly accurate, non-invasive, disposable breath test that aims to detect the virus before the onset of symptoms, in less than three minutes

A new study published today in the National Kidney Foundation ‘s American Journal of Kidney Diseases (AJKD) has found that it is possible to accurately assess patients for the stages of kidney disease without using race in the equation, which is currently routinely used as part of the diagnosis process in the United States .

The pandemic has had a marked impact on the demand for social services — and the social determinants of health are directly related to rates of infection and mortality rates for COVID-19. On Tues

SOLVD Health (www.solvdhealth.com), a privately held company focused on preventing disease by making actionable and contextual health information accessible to everyone, announced today that its genetic risk assessment for opioid use disorder (OUD) has received CE mark certification.

Rocket Pharmaceuticals Presents Positive Clinical Data from its Fanconi Anemia and Leukocyte Adhesion Deficiency-I Programs at the 62 nd American Society of Hematology Annual Meeting –Two of Three FA “Process B” Patients with at Least 12-Months Follow-Up and Three of Four Additional Patients with Shorter Follow-Up Demonstrate Evidence of Engraftment— – Follow-Up Data from Phase 1/2 Trial for Leukocyte Adhesion Deficiency-I

The American Academy of Orthopaedic Surgeons invites journalists and print, online and broadcast news outlets to submit content to be considered for the 2021 Media Orthopaedic Reporting Excellence Awards.

StoneBridge Healthcare, LLC (StoneBridge), an innovative company formed to buy, save and turn around distressed hospitals in the cities and suburbs of America, today announced it has presented a Letter of

Everlywell, a leading digital health company and provider of one of the only FDA-authorized at-home sample collection kits for COVID-19, today announced it has entered into a distribution agreement with diagnostics manufacturer Cellex, the first company to receive an FDA Emergency Use Authorization for a COVID-19 antibody test.

Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that it will host a conference call and webcast to review the status and provide a clinical update for its three most advanced TriTAC® programs